Amphastar Announces FDA Approval for Iron Sucrose Injection, USP

Go back to Amphastar Announces FDA Approval for Iron Sucrose Injection, USP
AMER PHYSICIANS (NASDAQ: AMPH) Delayed: 20.78 +0.97 (4.90%)
Previous Close $19.81    52 Week High $21.53 
Open $22.48    52 Week Low $10.50 
Day High $22.65    P/E 6.35 
Day Low $20.40    EPS $3.27 
Volume 1,300,479